- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04467606
Motivational Interview Based Discharge Planning for Patients With Diabetic Foot Ulcers
Institutional Review Board Chang Gung Medical Foundation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to evaluate the effectiveness of a discharge planning using the strategy of motivational interviewing among patients with diabetic foot ulcers.
A randomized controlled trial design will be used. From August 2020 to July 2022, 132 patients hospitalized for diabetic foot ulcers will be recruited. They will be randomly assigned to either the experimental or the comparison group in the first year, and then they will be followed by one year. The control group will receive routine care; the experimental group will receive a discharge planning which use the strategy of motivational interviewing. The discharge planning will be provided individually at the following time points: before discharge, on post-discharge days 3, 7, 14, 21, 28, and then each month till one year. Outcome measures include diabetic foot ulcer self-care behaviors and self-efficacy, foot skin conditions, glycemic control (measured by HbA1C), the infection rate of foot, and the readmission rate. Data will be collected at baseline and at 1, 3, 6, and 12 months after discharge.
The generalized estimating equation (GEE) will be used to evaluate the effect of the intervention on the diabetic foot ulcer self-care behaviors and self-efficacy, foot skin conditions, and the effect on glycated hemoglobin value reduction. The log-rank test will be used to compare the infection rate of foot, and the readmission rate between two groups.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yen-Fan Chin, PhD
- Phone Number: 5189 886032118800
- Email: yenfan@mail.cgu.edu.tw
Study Locations
-
-
-
Taoyuan City, Taiwan
- Chang Gung Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Experimental
The experimental group will receive a discharge planning which use the strategy of motivational interviewing.
|
The experimental group will receive a discharge planning which use the strategy of motivational interviewing.
The discharge planning will be provided individually at the following time points: before discharge, on post-discharge days 3, 7, 14, 21, 28, and then each month till one year.
|
NO_INTERVENTION: Control
Participants will receive routine care of the research setting only.
The counseling will be provided if participants request.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of foot infection and readmission for foot ulcer
Time Frame: 5 minutes
|
Foot assessment and the review of medical record
|
5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic control
Time Frame: 1 minutes
|
Review the Glycated hemoglobin value on the medical record
|
1 minutes
|
Foot skin conditions
Time Frame: 1 minutes
|
Foot assessment
|
1 minutes
|
Knowledge regarding warning signs of diabetic foot ulcer
Time Frame: 5 minutes
|
The WS-DFUD-KQ comprises of 12 items. Three of the 12 items are negatively worded and state as misconceptions regarding warning signs of diabetic foot ulcer deterioration (i.e. item 8, 9, 10). The response choices include "yes," "no," and "uncertain." Each item with the correct answer obtains a score of 1, after which the scores are summed to obtain a total score. The higher scores represent better knowledge. The total WS-DFUD-KQ score ranges 0-12. The content validity index of each of the 12 items was above 0.8. The item difficulty of the 12 items of the WS-DFUD-KQ ranged from 0.54 to 0.87, and the item discrimination index D values ranged from 0.42 to 0.83. The KR-20 of the WS-DFUD-KQ was 0.82. The Spearman's rho coefficient for test-retest reliability over a two-week period was 0.75. |
5 minutes
|
Diabetes Foot Self-Care Behavior
Time Frame: 3 Minutes
|
The Diabetes Foot Self-Care Behavior Scale (DFSBS) contains 7 items.
The scale has two parts: In the first part, the responses are rated on the number of days patients performed a certain behavior over the course of one week.
In the second part, the responses are rated by the frequency with which patients performed a certain behavior in general, from never (1) to always (5).
When the score of the total scale is calculated, the number of days for each foot-care measure in the first part is categorized across 5 groups (0 days, 1-2 days, 3-4 days, 5-6 days, and 7 days).
Thus, all items on the scale are rated on a 5-point Likert-type scale with the higher scores represented better foot self-care behaviors.
The total DFSBS score ranges 7-35.
|
3 Minutes
|
Self-care behaviors of diabetes
Time Frame: 4 Minutes
|
The Chinese version of summary of diabetes self-care activity questionnaire (C-SDSCA) is a short self-reported questionnaire of diabetes self-management across five components of diabetes regimen a person with diabetes should practice in order to stay well ( i. e. diet, exercise, blood sugar testing, foot care and attention to smoking).
The number of days for each diabetes self-management behavior is measured.
The higher scores represented better self-care behaviors of diabetes.
The total C-SDSCA score ranges 11-77.
|
4 Minutes
|
Diabetes-related Foot Ulcer Self-Management Behavior
Time Frame: 9 Minutes
|
The Diabetes-related Foot Ulcer Self-Management Behavior Scale (DFUSMBS) measures behaviors that patients use to manage their diabetes-related foot ulcers to promote wound healing and to prevent the deterioration of their wounds, including timely treatment seeking and management, wound management, and self-management of diabetes.
The 18-item scale includes three reverse-scored items (Item 1, 2, 11) and uses a 5-point Likert scale (1 = never, 2 = seldom, 3 = sometimes, 4 = frequently, and 5 = always).
The higher scores represent better diabetes-related foot ulcer self-management behaviors.
The total DFUSMBS score ranges 18-90.
|
9 Minutes
|
Diabetes management self-efficacy
Time Frame: 10 Minutes
|
The Chinese version of the Diabetes Management Self-Efficacy Scale (C-DMSES) is a self-administered scale containing 20 items.
It assesses the extent to which respondents are confident that they could manage their blood sugar, diet, and level of exercise.
Responses are rated on a 10-point Likert-style from not at all (1) to certainly can do (10).
The responses are summed to become a total score for "self-efficacy".
Possible scores range from 0 to 200 points.
The tool had acceptable reliability and validity in a Taiwanese population.
|
10 Minutes
|
Self-efficacy regarding diabetes foot self-care
Time Frame: 1 Minute
|
Two items will be used to measure the self-efficacy regarding diabetes foot self-care of participants.
They are "I have confidence to check my feet (including the bottom of my feet and between the toes) daily, either by myself or to ask for someone's help.", and "I have confidence to apply moisturizing lotion to my feet by myself or asking for someone's help, If my skin is dry".
Responses are rated on a 10-point Likert-style scale according the degree of confidence.
|
1 Minute
|
Self-efficacy regarding diabetes-related foot ulcer self-management
Time Frame: 5 Minutes
|
The 16-item diabetes-related foot ulcer self-management self-efficacy scale will be used to measure the confidence in delivering diabetic foot ulcer self-management behavior, and management of diabetic foot ulcer.
Responses are rated on a 10-point Likert-style from not at all (1) to certainly can do (10).
The higher score indicates better self-efficacy.
|
5 Minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201901813B0
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Foot Ulcer
-
University of MinnesotaRecruitingDiabetes Mellitus | Foot Ulcer | Ulcer | Diabetic Foot Ulcer | Foot Ulcer, Diabetic | Ulcer Foot | Ulcer, Leg | Ankle UlcerUnited States
-
Community Pharmacology Services LtdKeneric HealthcareNot yet recruitingDiabetic Foot Ulcer | Diabetic Foot Ulcer Neuropathic | Diabetic Foot Ulcer Ischemic
-
University of PadovaUnknownDiabetic Foot | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Deformities FootItaly
-
Corporacion Parc TauliCompletedDiabetic Foot Ulcer | Diabetic Foot Ulcer NeuropathicPakistan
-
Johns Hopkins UniversityWithdrawnDiabetic Foot | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Mixed | Vascular Ulcer (Arterial or Venous Including Diabetic Ulcers Not Located on the Foot)
-
Baylor College of MedicineLifeNet HealthCompletedDiabetic Foot Ulcer | Deep Diabetic Foot UlcerUnited States
-
ETS Wound Care, LLCProfessional Education and Research InstituteCompletedDiabetic Foot | Diabetic Foot Ulcer | Ulcer FootUnited States
-
Exciton Technologies Inc.CompletedDiabetic Foot Ulcer | Diabetic Foot Infection | Non-healing Diabetic Foot UlcerCanada
-
National and Kapodistrian University of AthensTerminatedDiabetic Foot | Chronic Diabetic Foot Ulcer of Right Foot | Neuropathic Foot Ulcer | Chronic Diabetic Ulcer of Left Foot (Diagnosis)Greece
-
University of the PunjabHigher Education Commission (Pakistan); Centre of Excellence in Molecular Biology... and other collaboratorsRecruitingDiabetes Mellitus | Diabetic Foot | Foot Ulcer | Diabetes Complications | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Foot Ulcer Due to Type 1 Diabetes Mellitus | Foot Ulcer Due to Type 2 Diabetes Mellitus | Chronic Diabetic Ulcer of Left Foot | Chronic Diabetic Foot...Pakistan
Clinical Trials on a discharge planning using the strategy of motivational interviewing
-
Qazvin University Of Medical SciencesCompletedCoronary Artery Bypass Grafting (CABG) SurgeryIran, Islamic Republic of
-
Kamuzu University of Health SciencesNational Heart, Lung, and Blood Institute (NHLBI)UnknownHypertension | Diabetes | Life StyleMalawi
-
University of HaifaCompletedExperimental | ControlIsrael
-
NYU Langone HealthCompletedPeripheral Artery DiseaseUnited States
-
University Hospital, LilleNational Research Agency, FranceCompleted
-
Cliniques universitaires Saint-Luc- Université...RecruitingNeuromuscular Diseases | Cough | Airway Clearance ImpairmentBelgium
-
University Hospital AugsburgRecruitingFractures, Bone | Bone Marrow EdemaGermany
-
University Hospital, RouenRecruiting
-
Radboud University Medical CenterMassachusetts General Hospital; McGill University; Hoffmann-La Roche; University... and other collaboratorsRecruitingBrain Diseases | Central Nervous System Diseases | Nervous System Diseases | Parkinson Disease | Parkinsonian Disorders | Basal Ganglia Diseases | Synucleinopathies | Neurodegenerative Diseases | REM Sleep Behavior Disorder | Prodromal Stage | Cerebral DisorderNetherlands